Bafna Pharmaceuticals Limited
Share Price Target & Analysis

NSE:BAFNAPH

304.68

VWAP

301.85

Open

308

Close

307.5

High

301.85

Low

318.5

52 Week High

301.85 ⇩
-6.15 (-2%)

BAFNAPH

(PHARMA)
92.6% Momentum

Trending & Favourite

94.77

52 Week Low

3.29

EPS

52.86

PE

7.42

PB

Economical
Quality

Diamond
Valuation

#Analysis

NSE: BAFNAPH Share Price Financial Analysis & Valuation

Bafna Pharmaceuticals Limited (BAFNAPH) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of SME Stocks company with Market Capitalization of Rs 321.7 (in Cr). Total number of free float shares are 0 (in Lacs). Bafna Pharmaceuticals Limited is listed on NSE with Exchange ID - INE878I01022 and trading code is NSE:BAFNAPH with short name Bafna Pharma.

In the past 1 year, Bafna Pharmaceuticals Limited has declared an equity dividend of Rs 0 per share. At the current share price of BAFNAPH at Rs 301.85, this results in a dividend yield of 0 %.

As per the Fundamental Analysis of NSE:BAFNAPH, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine BAFNAPH underlying value and future prospects. All of this data is available in BAFNAPH financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:BAFNAPH, it is clearly understood that BAFNAPH is Economical performer in terms of earnings and profit margins with an EPS of 3.29. NSE:BAFNAPH book value per share as of today is 40.68. The current price to book ratio for BAFNAPH as of Oct 24, 2026 is 7.42.

Valuation of the Stock: The current valuation of BAFNAPH stock is like Diamond which means currently the stock is Very Expensive. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of BAFNAPH whether to BUY this stock at current valuation. The delivery percentage of BAFNAPH is 0% is very crucial parameter which shows that 0% investors are anticipating that the price of BAFNAPH share should go up with VWAP at 304.68.

Now, the main question is whether to BUY or SELL, NSE:BAFNAPH at current valuation.
As per latest Analysis No. #1241:-

⇑ STRONG BUY BAFNAPH if All Greens

⇗ BUY BAFNAPH (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD BAFNAPH (With Stop Loss) if only 1 Green

⇘ SELL BAFNAPH if NO Green Indicator

NSE: BAFNAPH Share Price Today (Oct 24, 2026)

(Bafna Pharmaceuticals Limited Daily Analysis on the basis of BAFNAPH Intraday Graph & Trend)

Bafna Pharmaceuticals Limited share price moved Down by -2% from its previous close of Rs 308. BAFNAPH stock last traded price is 301.85. BAFNAPH share price trend is Down with a total of 4454 stocks traded till now. It has touched an intraday high of Rs 307.5 and an intraday low of Rs 301.85. The BAFNAPH trading at 301.85, Down by Rs. -6.15, or -2 percent which suggests that most of the Traders are anticipating that the price of BAFNAPH share should go Down.

NSE: BAFNAPH Share Price Tomorrow Prediction

(Bafna Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of BAFNAPH)

Bafna Pharmaceuticals Limited share price moved Down by -2%. BAFNAPH share price short term trend is Down. It suggests that BAFNAPH Share Price for Tomorrow remains the same with VWAP at 304.68 will be treated as stop loss for intraday traders. Bafna Pharmaceuticals Limited Long term investors can follow the BAFNAPH long term trend as mentiond in future forecast table.

NSE Code

NSE: BAFNAPH

BAFNAPH Share Price Today

 301.85

BAFNAPH Share Price Target Prediction for 2026 ^

 199.2 - 320.1

BAFNAPH Share Price Target Prediction for 2027*^

 320.1 - 341

BAFNAPH Share Price Target Prediction for 2028*^

 341 - 364.9

BAFNAPH Share Price Target Prediction for 2029*^

 383

BAFNAPH Share Price Target Prediction for 2030*^

 394

BAFNAPH Share Price Target Prediction for 2035*^

 430
BAFNAPH Current Book Value
40.5

*Bafna Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^BAFNAPH share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

BAFNAPH Technical Analysis

Candlestick Pattern: @301.6

BAFNAPH Moving Averages

BUY (12) NEUTRAL (0) SELL (2)
MA Simple Action S1 Expo Action E2
MA_5 301.76 SELL 302.08 SELL
MA_12 292.67 BUY 292.63 BUY
MA_20 277.4 BUY 284.69 BUY
MA_32 272.41 BUY 270.28 BUY
MA_50 255.17 BUY 255.01 BUY
MA_100 211.6 BUY 225.88 BUY
MA_200 166.25 BUY 183.08 BUY

BAFNAPH Trend Oscillators

BUY (4) NEUTRAL (0) SELL (0)
Trend Oscillators Value Action
Bollinger Bands 277.4 Uptrend
MACD 1.11 BUY
ADX 32.48 Strong Trend
DMI (+/-) 53.4 / 30.99 Uptrend

BAFNAPH Momentum Oscillators

BUY (3) NEUTRAL (8) SELL (1)
Momentum Oscillators Value Action
RSI 63.67 Neutral
STOCHASTIC_K (Fast) 57.29 Neutral
STOCHASTIC_D (Slow) 51.54 Neutral
CCI 52.5 Neutral
PSAR 286.13 BUY
TRUE RANGE 6.15 Neutral
ATR 8.15 Neutral
WILLIAMS R -19.75 Overbought
TRIX 0 Neutral
STOCHASTIC RSI K 0 Oversold
STOCHASTIC RSI D 22.81 Neutral
MOMENTUM 27.85 BUY

BAFNAPH Last 1 Year Trend

Duration Value
1 Year 201.69%
3 Months 72.76%
1 Month 10.17%
1 Week -2.08%

BAFNAPH Technical Analysis Summary

Updated on 2026-09-09
Action Overall (%)
BUY 63%
NEUTRAL / HOLD 27%
SELL 10%

(powered by Zerodha)

Most popular Questions & Answers about BAFNAPH

Bafna Pharmaceuticals Limited Frequently Asked Questions (FAQs)

Bafna Pharmaceuticals Limited stock last traded price is 301.85. BAFNAPH share price moved Down by -2% from its previous close of Rs 308.

Bafna Pharmaceuticals Limited share price trend is Down with a total of 4454 stocks traded till now. It has touched an intraday high of Rs 321.685 and an intraday low of Rs 301.85. The BAFNAPH trading at 301.85, Down by Rs. -6.15, or -2 percent which suggests that most of the Traders are anticipating that the price of BAFNAPH share should go Down and the Stop Loss will be around 304.68.

The market cap of Bafna Pharmaceuticals Limited is ₹321.7 (in Cr) as of Oct 23, 2026.

The current price to earning ratio for Bafna Pharmaceuticals Limited as of Oct 23, 2026 is 52.86.

The current price to book ratio for Bafna Pharmaceuticals Limited as of Oct 23, 2026 is 7.42.

The highest price of Bafna Pharmaceuticals Limited stock is ₹318.5 in the last 52-week.

The lowest price of Bafna Pharmaceuticals Limited stock is ₹94.77 in the last 52-week.

Bafna Pharmaceuticals Limited share trading at ₹301.85, Down by Rs. -6.15, or -2 percent which suggests that most of the traders are anticipating that the price of BAFNAPH share should go Down.

In 2026, Stock price target for Bafna Pharmaceuticals Limited (BAFNAPH) will be around ₹199.2 on downside and ₹320.1 on upside. Bafna Pharmaceuticals Limited share price target is based on current financial year earings of the company.

In 2027, Stock price target for Bafna Pharmaceuticals Limited (BAFNAPH) will be around ₹320.1 on downside and ₹341 on upside. Bafna Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.

In 2028, Stock price target for Bafna Pharmaceuticals Limited (BAFNAPH) will be around ₹341 on downside and ₹364.9 on upside. Bafna Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Bafna Pharmaceuticals Limited (BAFNAPH) will be around ₹394 Bafna Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of BAFNAPH.

The price of Bafna Pharmaceuticals Limited (BAFNAPH) shares moved by -2%. The short-term trend for BAFNAPH share price is Down. It implies that the share price of BAFNAPH will stay the same tomorrow and that intraday traders should treat VWAP at 304.68 as a stop loss. Investors with a long-term outlook can track BAFNAPH long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of BAFNAPH stock is 39.4. Compared to the current market price of 301.85 INR, the BAFNAPH stock is Overvalued by 86.9%.

As per the fundamental analysis of Bafna Pharmaceuticals Limited (BAFNAPH), it is of Economical quality in terms of earnings and profit margins with an EPS of 3.29. Bafna Pharmaceuticals Limited book value per share as of today is 40.68. The current price to book ratio for BAFNAPH as of Oct 24, 2026 is 7.42.


NSE:BAFNAPH News & Other Useful Information about BAFNAPH Share Price


Peer Comparison of NSE: BAFNAPH

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1748.00 16.35 97.89
DIVISLAB 8950.00 115.55 663.06
MEDICAMEQ 253.35 12.15 208.08
CIPLA 1338.00 51.67 434.02
DRREDDY 1229.50 53.19 380.63
TORNTPHARM 4524.40 87.32 235.7
BIOCON 323.50 1.27 166.51
LUPIN 1928.90 154.86 718.33
ALKEM 4947.00 212.33 1218.48
AUROPHARMA 1571.70 46.49 403.84
ABBOTINDIA 25030.00 766.11 2448.41
GLAXO 2404.70 63.65 147.25
IPCALAB 1953.30 56.72 329.23
LAURUSLABS 1970.00 20.74 102.57
LALPATHLAB 1838.20 39.68 157.23
PFIZER 3612.30 170.54 963.41
AJANTPHARM 3283.90 89.3 363.23
SANOFI 2772.80 158.05 332.96
NATCOPHARM 791.85 82.14 505
APLLTD 760.10 48.4 295.69
JBCHEPHARM 2408.90 54.16 251.48
GLENMARK 2166.60 1.24 881.78
AAREYDRUGS 106.73 2.39 53.38
JUBLPHARMA 938.30 4.35 145.63
SPARC 171.77 48.14 40.45
GRANULES 794.75 23.25 180.42
ASTRAZEN 5988.50 86.44 364.29
CAPLIPOINT 2222.00 55.52 285.6
FDC 338.70 21.19 161.21
HIKAL 193.65 9.34 96.63
Updated at: 03 Sep 2026 15:15:03

Feel free to contact us, in case of any queries.

Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2477.00 -73.00 (-2.86%) | ADANIPORTS 1702.70 -47.30 (-2.7%) | APOLLOHOSP 7730.00 125.50 (1.65%) | ASIANPAINT 2307.00 22.20 (0.97%) | AXISBANK 1217.50 5.50 (0.45%) | BAJAJ-AUTO 10072.00 -83.00 (-0.82%) | BAJAJFINSV 1655.00 -23.00 (-1.37%) | BAJFINANCE 928.95 -13.15 (-1.4%) | BEL 362.00 -2.50 (-0.69%) | BHARTIARTL 1892.10 -2.90 (-0.15%) | CIPLA 1338.00 7.10 (0.53%) | COALINDIA 397.45 -5.10 (-1.27%) | DRREDDY 1229.50 -9.50 (-0.77%) | EICHERMOT 7066.00 -18.50 (-0.26%) | GRASIM 2894.00 -0.40 (-0.01%) | HCLTECH 1422.20 0.50 (0.04%) | HDFCBANK 692.80 -1.25 (-0.18%) | HDFCLIFE 523.75 -4.60 (-0.87%) | HINDALCO 869.85 -15.75 (-1.78%) | HINDUNILVR 1814.70 -13.60 (-0.74%) | ICICIBANK 1394.20 -4.30 (-0.31%) | INDIGO 4549.00 -51.00 (-1.11%) | INFY 1153.80 0.45 (0.04%) | ITC 257.90 -1.00 (-0.39%) | JIOFIN 205.03 -5.77 (-2.74%) | JSWSTEEL 1185.50 -34.50 (-2.83%) | KOTAKBANK 430.50 -6.50 (-1.49%) | LT 3647.00 8.70 (0.24%) | M&M 2861.20 -2.90 (-0.1%) | MARUTI 11230.00 60.00 (0.54%) | MAXHEALTH 815.00 -2.00 (-0.24%) | NESTLEIND 1175.00 -14.90 (-1.25%) | NTPC 298.00 -4.60 (-1.52%) | ONGC 227.50 2.50 (1.11%) | POWERGRID 247.40 -1.00 (-0.4%) | RELIANCE 1190.00 5.50 (0.46%) | SBILIFE 1640.00 -2.90 (-0.18%) | SBIN 958.60 -11.40 (-1.18%) | SUNPHARMA 1748.00 -10.00 (-0.57%) | TATACONSUM 963.90 4.10 (0.43%) | TATASTEEL 167.67 -4.66 (-2.7%) | TCS 2530.00 23.10 (0.92%) | TECHM 1790.00 -39.10 (-2.14%) | TITAN 4299.70 -50.30 (-1.16%) | TMPV 264.60 -5.40 (-2%) | TRENT 2727.50 -48.30 (-1.74%) | ULTRACEMCO 11050.00 92.00 (0.84%) | WIPRO 189.84 -0.57 (-0.3%) |
Top